-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
8 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$18.21 M
Cerevel Therapeutics Holdings, Inc. Insider Transactions
Cerevel Therapeutics Holdings, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
COLES N ANTHONY
Director |
Sell | 50,000 @ $40.61 | $2.03 M | 15,638 | 06/03/2024 | 06/05/2024 | |
|
COLES N ANTHONY
Director |
Sell | 50,000 @ $42.10 | $2.11 M | 15,638 | 05/10/2024 | 05/14/2024 | |
|
COLES N ANTHONY
Director |
Sell | 50,000 @ $42.33 | $2.12 M | 15,638 | 04/01/2024 | 04/03/2024 | |
|
COLES N ANTHONY
Director |
Sell | 50,000 @ $41.01 | $2.05 M | 15,638 | 03/04/2024 | 03/06/2024 | |
|
COLES N ANTHONY
Director |
Sell | 50,000 @ $41.16 | $2.06 M | 15,638 | 02/29/2024 | 03/04/2024 | |
|
Renger John
Chief Scientific Officer |
Sell | 2,161 @ $41.54 | $89,777 | 6,370 | 02/07/2024 | 02/08/2024 | |
|
COLES N ANTHONY
Director |
Sell | 2,506 @ $41.54 | $104,110 | 15,638 | 02/07/2024 | 02/08/2024 | |
|
COLES N ANTHONY
Director |
Sell | 50,000 @ $42.24 | $2.11 M | 2,704 | 01/02/2024 | 01/04/2024 | |
|
Sanchez Ramiro
Chief Medical Officer |
Sell | 10,000 @ $42.47 | $424,700 | 14,673 | 12/26/2023 | 12/28/2023 | |
|
DiPietro Kenneth
Chief Human Resources Officer |
Sell | 8,000 @ $41.45 | $331,608 | 24,663 | 12/22/2023 | 12/27/2023 | |
|
Bodenrader Mark
See Remarks |
Sell | 7,889 @ $41.42 | $326,788 | 17,724 | 12/20/2023 | 12/21/2023 | |
|
DiPietro Kenneth
Chief Human Resources Officer |
Sell | 6,256 @ $41.42 | $259,144 | 24,663 | 12/20/2023 | 12/21/2023 | |
|
Akamine Scott
Chief Legal Officer |
Sell | 7,072 @ $41.42 | $292,945 | 7,237 | 12/20/2023 | 12/21/2023 | |
|
Sanchez Ramiro
Chief Medical Officer |
Sell | 10,152 @ $41.42 | $420,528 | 14,673 | 12/20/2023 | 12/21/2023 | |
| Sell | 13,808 @ $41.42 | $571,972 | 16,913 | 12/20/2023 | 12/21/2023 | ||
|
Tregoning Kathleen
See Remarks |
Sell | 6,288 @ $41.42 | $260,469 | 7,516 | 12/20/2023 | 12/21/2023 | |
|
Sanchez Ramiro
Chief Medical Officer |
Sell | 7,500 @ $41.39 | $310,393 | 0 | 12/15/2023 | 12/19/2023 | |
|
Sanchez Ramiro
Chief Medical Officer |
Sell | 10,000 @ $41.37 | $413,700 | 0 | 12/07/2023 | 12/11/2023 | |
|
Akamine Scott
Chief Legal Officer |
Sell | 10,000 @ $41.37 | $413,700 | 513 | 12/07/2023 | 12/07/2023 | |
|
Akamine Scott
Chief Legal Officer |
Sell | 7,500 @ $35.00 | $262,500 | 513 | 12/05/2023 | 12/07/2023 |
Cerevel Therapeutics Holdings, Inc. Frequently Asked Questions
-
Who is on Cerevel Therapeutics Holdings, Inc.'s Insider Roster?
The list of insiders at Cerevel Therapeutics Holdings, Inc. includes COLES N ANTHONY, Akamine Scott, Sanchez Ramiro, Tregoning Kathleen, ALTSCHULLER Susan, DiPietro Kenneth, Bodenrader Mark, Renger John.
-
How much insider selling is happening at Cerevel Therapeutics Holdings, Inc.?
Insiders have sold a total of 459,132 Cerevel Therapeutics Holdings, Inc. shares in the last 12 months for a total of 18.21 M sold.
-
Which Cerevel Therapeutics Holdings, Inc. insiders have been selling company stock?
The following insiders have sold Cerevel Therapeutics Holdings, Inc. shares in the last 12 months: COLES N ANTHONY ($13.83 M), Akamine Scott ($969,145), Sanchez Ramiro ($1.57 M), Tregoning Kathleen ($260,469), ALTSCHULLER Susan ($571,972), DiPietro Kenneth ($590,752), Bodenrader Mark ($326,788), Renger John ($89,777),